An observational study in Artificial Intelligence, Optical Enhancement Endoscopy and Magnifying Endoscopy, sponsored by Shandong University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-28.
Sponsored by Shandong University · Observational
Esophageal squamous cell carcinoma is one of the most common malignant tumor of upper digestive tract. However, the detection rate and diagnosis accuracy of early esophageal squamous cell cancer is low. The aim of this study is to develop a computer-assisted diagnosis tool combining with optical magnifying endoscopy for early detection and accurate diagnosis of it.
1,772 studies on the registry are indexed under Carcinoma, Squamous Cell; 412 are open to participants now.
This study's enrollment of 119 is above the median of 100 across 268 observational studies indexed under Carcinoma, Squamous Cell.
Browse Carcinoma, Squamous Cell studies →Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Consecutive patients who came to Qilu Hospital of Shandong University and received optical magnifying OE endoscopy examination
Exclusion Criteria:
the endoscopic novices analyzing the images can see the automatic diagnosis of AI during the process
Other: AI presentation
the endoscopic novice analyzing the images can not see the automatic diagnosis of AI during the process
Other: no AI presentation
AI presentation means the automatic diagnosis information of AI and AI presentation means it is visible in the group.
AI presentation means the automatic diagnosis information of AI and no AI presentation means it is invisible in the group.
the diagnosis efficiency of the AI model
the sensitivity, specificity and accuracy of the AI model
Time frame: 12 months
This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shandong University